Company intelligence
BIOAXXENT GmbH
Pharmaceutical Manufacturing
Betzdorf, DE
2 employees
5 public signals
About BIOAXXENT GmbH
BIOAXXENT GmbH is a highly innovative startup aiming to revolutionize drug delivery with microneedle technology.
Verified activity
Signals from BIOAXXENT GmbH
5 published signals
Research & Knowledge
BIOAXXENT GmbH published a recent review in Advanced Drug Delivery Reviews highlighting how biologic drug delivery is expanding beyond conventional injections, including advanced lipid and polymer formulations, sustained-release systems, site-specific delivery, and drug-device combinations.
Reported by BIOAXXENT GmbH
Presence & Recognition
BIOAXXENT GmbH is attending the CPHI Milan event at Fiera Milano from 6 to 8 October 2026.
Reported by BIOAXXENT GmbH
Research & Knowledge
BIOAXXENT GmbH researchers developed biodegradable PLGA implants for long-term buprenorphine delivery designed to sustain therapeutic exposure for three months or longer.
Reported by BIOAXXENT GmbH
Research & Knowledge
BIOAXXENT GmbH published a first-in-human study testing a bioresorbable subcutaneous naltrexone implant designed to provide sustained drug delivery for 6 to 12 months in healthy volunteers.
Reported by BIOAXXENT GmbH
Research & Knowledge
BIOAXXENT GmbH published a study showing that researchers developed a smart hydrogel that responds to an external magnetic field and releases 5-fluorouracil on demand.
Reported by BIOAXXENT GmbH